Biobot Surgical

Biobot Surgical At Biobot Surgical, our mission is to revolutionize the realm of robotic-assisted biopsy and treatment for prostate cancer.

04/03/2025

Mona Lisa 2.0 CE Certified. Precision That Matters.
Transforming Prostate Care with Precision that Matters.

Dr. Sritharan Subramaniam shares he recommends Biobots Mona Lisa for prostate cancer biopsy for several reasons.

“Its MRI-US fusion technology ensures precise targeting, while the robotic arm delivers 1mm accuracy at the required depth. The active interface allows real-time input to adjust for needle deflection or patient movement, ensuring consistent precision.

The system also offers flexibility in planning and ex*****on, along with the transperineal approach, which is safer and reduces the risk of infection. Together, these features enhance cancer detection, ultimately benefiting patients with more accurate diagnoses and better outcomes.”

Discover how Biobot Surgical is shaping the future of prostate health.

26/02/2025

Mona Lisa 2. 0, CE Certified. Precision that matters.
Accelerating Precision in Prostate Cancer Care with Mona Lisa

Dr. Terrence Lim, Medical Director at Assure Healthcare, shares how the Mona Lisa revolutionizes prostate cancer diagnostics with its unparalleled ease of adoption:

"With its short learning curve, doctors can quickly master the system and deliver precise, efficient diagnoses."

With robotic precision within 1.0mm, the Mona Lisa empowers healthcare professionals to provide greater accuracy, minimize risks, and improve patient outcomes—setting a new standard in urological care.

At Biobot Surgical, we are proud to support physicians in transforming lives through cutting-edge technology. The future of prostate cancer care is here.

11/02/2025

Mona Lisa 2.0, CE certified. Precision that Matters.

Our robotic system takes biopsy accuracy to the next level, precisely controlling needle trajectory and depth to target suspicious areas.
A recent study showed residents reached proficiency after just 22 cases, performing procedures as well as an experienced doctor from there on!
“The Mona Lisa system has greatly enhanced precision of our biopsies… providing highly accurate control of the biopsy needle, controlling both trajectory and pe*******on depth and therefore allowing precise targeting of suspicious areas.”

# Prof Christian Wetterauer

04/02/2025

Mona Lisa 2.0, CE certified. Precision that Matters.

“Robotic-assisted needle positioning provides accuracy within 1.0mm, while using the transperineal approach which reduces complications and infection rates”
Prof John Yuen, who is one of the inventors of BIOBOT’s MONA LISA continues to treat patients at Singapore General Hospital.

21/01/2025

FDA Approved and NOW with CE certification.

93% Detection Rate for Clinically Significant Prostate Cancer!

A study at RUSH University assessed the effectiveness of the Mona Lisa fusion system for robot-assisted transperineal prostate biopsies across 42 patients — and the results speak for themselves.
> 93% detection rate for clinically significant prostate cancer> Median procedure time of just ~30 minutes> Improved efficiency over time, with ZERO technical issues

These data reinforce the Mona Lisa robotic system is transforming prostate cancer diagnosis, offering accuracy and speed to urologists and their patients.

Stay tuned as we continue pushing the boundaries of precision in prostate care!
hashtag hashtag hashtag hashtag hashtag hashtag

14/01/2025

We are thrilled to share some exciting news. Our flagship robotic platform, the Mona Lisa 2.0, has officially received CE Certification! This achievement marks an exciting new chapter for prostate care across Europe and beyond.

This milestone is more than regulatory approval—it’s a validation of our unwavering commitment to innovation, precision, and improving outcomes for urologists and their patients.

The Mona Lisa 2.0 represents years of collaboration with key opinion leaders, engineers, and clinicians who are equally passionate about transforming prostate disease management.

Major Milestone Achieved: 50 Mona Lisa Robots Deployed Worldwide!We're proud to share a significant moment for us at BIO...
27/02/2024

Major Milestone Achieved: 50 Mona Lisa Robots Deployed Worldwide!

We're proud to share a significant moment for us at BIOBOT - the deployment of our 50th Mona Lisa robot globally. This achievement underscores our commitment to pioneering prostate disease management through superior technology.

🌍 From the USA to the Asia-Pacific, each Mona Lisa robot represents a step forward in our mission to improve patient outcomes with robotic precision.

🩺This success is a testament to the trust of urologists, investors, partners, and the broader medical community. Your support empowers our team at BIOBOT to push the boundaries of medical innovation.

🌅 As we mark this milestone, our eyes are set on the future - expanding our technology's reach and continuing to impact lives positively. Thank you to everyone who has joined us on this journey.

Visit our website to learn more about BIOBOT and how we are advancing a new era in prostate disease management. www.Biobotsurgical.com

Exciting update from Biobot: Reflecting Our Progress Through Our Evolved BrandWe are proud to share an important milesto...
27/02/2024

Exciting update from Biobot: Reflecting Our Progress Through Our Evolved Brand

We are proud to share an important milestone in Biobot’s evolution - a refreshed brand that mirrors the significant strides we've made in advancing prostate cancer management and treatment. This update is more than just a new look; it's a reflection of our real-world impact, our collaboration with healthcare professionals worldwide, and our commitment to providing precision in diagnosis and health management through technology.

Our journey has been marked by the relentless pursuit of excellence and innovation in robotic-assisted surgeries. This enhanced identity is inspired by the feedback from those we serve: urologists, patients, and healthcare partners. It symbolizes the precision, care, and forward-thinking approach that define our contributions to healthcare.

As Biobot Surgical continues to grow and innovate, our updated brand is a testament to the progress we've achieved together with our partners and the global community. Together, we are setting new standards in urological care, with minimally invasive procedures that lead to better patient outcomes, and expanding access to cutting-edge solutions worldwide. Thank you for being an integral part of our journey.

Experience the new Biobot brand today. http://biobotsurgical.com/

🎄✨ Wishing you a Merry Christmas from Biobot Surgical! 🎅🌟As the holiday season unfolds, Biobot Team sends warm wishes fo...
22/12/2023

🎄✨ Wishing you a Merry Christmas from Biobot Surgical! 🎅🌟
As the holiday season unfolds, Biobot Team sends warm wishes for a joyful Christmas!
May your celebrations be filled with love, laughter, and cherished moments with loved ones. Here's to a fantastic holiday season and a prosperous New Year! 🎄✨

🌟 Elevating Expertise Together! 🌟 We're thrilled to have provided hands-on training on Mona Lisa, led by Prof Christian ...
10/11/2023

🌟 Elevating Expertise Together! 🌟

We're thrilled to have provided hands-on training on Mona Lisa, led by Prof Christian Wetterauer at . Empowering urologists with cutting-edge knowledge for unparalleled success in the diagnosis of prostate cancer. 💼✨


09/10/2023

📢Presenting "Learning curve of robotic-assisted transperineal MRI/Ultrasound fusion-guided prostate biopsy"
Highlights:
📌 Regardless of previous biopsy experience, a proficient performance is feasible as of 22 cases with Mona Lisas Robotic Assisted Transperineal Fusion Biopsies versus a much higher 65-120 cases for other Transperineal Platforms.
📌 This reduced learning curve in Mona Lisa is due to accuracy offered by automatization of robotic technology.

Thrilled to share that Prof. Dr. Christian Wetterauer, will be presenting at the upcoming 43rd Congress of the Société Internationale d'Urologie!

This research addresses the learning curve amongst different users of Mona Lisa. We encourage all attendees to visit this poster presentation to gain valuable insights into this fascinating topic. It's a wonderful opportunity to engage with a leading expert in the field and contribute to meaningful discussions.

📅 Date: 13 Oct 2023
🕒 Time: 13.45-15.15
📍 Venue: Société Internationale d'Urologie

Our EMEA team, led by Giansante Alessandrini, recently had the privilege of conducting an effective learning webinar exp...
29/09/2023

Our EMEA team, led by Giansante Alessandrini, recently had the privilege of conducting an effective learning webinar experience for our physicians based in Qatar, showcasing the robotic capabilities of our company's flagship product, Mona Lisa 2.0 🚀
We were thrilled to see such active participation and engagement from our customers, who asked insightful questions and provided valuable feedback. It's moments like these that reaffirm our commitment to delivering top-notch solutions tailored to our clients' needs.

Highlights of Biobots’ Mona Lisa 2.0 :

📌 Transperineal MRI-ultrasound fusion targeted prostate biopsy with precision and ease.
📌 Provide physicians with complete prostate coverage, aided through robotic targeting and accurate biopsy needle positioning.
📌 Prostate stability with ultrasound probe sheath.
📌 Dual cone approach ensuring multiple needle entry through the same channel.
📌 Accommodate for patient’s prostate movements during procedure with fine adjustments of up to 0.2mm.

Address

79 Ayer Rajah Crescent, #04/05
Sembawang
139955

Opening Hours

Monday 09:00 - 18:00
Tuesday 09:00 - 18:00
Wednesday 09:00 - 18:00
Thursday 09:00 - 18:00
Friday 09:00 - 18:00

Telephone

+65 6351 1868

Website

Alerts

Be the first to know and let us send you an email when Biobot Surgical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Biobot Surgical:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category